Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. - Kavanaugh,A.; St,C.lair EW.; McCune,W.J. (J Rheumatol, 2000)